A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Herpes SimplexHIV Infections
Interventions
DRUG

Valacyclovir hydrochloride

DRUG

Acyclovir

Trial Locations (22)

10011

Saint Vincent's Hosp and Med Ctr, New York

22203

Infectious Disease Physicians Inc, Annandale

30303

Emory Univ School of Medicine, Atlanta

33612

Univ of South Florida, Tampa

36604

Univ of South Alabama, Mobile

37232

Vanderbilt School of Medicine, Nashville

39216

Univ of Mississippi Med Ctr, Jackson

46202

Infectious Diseases Research Clinic / Indiana Univ Hosp, Indianapolis

60611

Northwestern Memorial Hosp, Chicago

60612

Rush Presbyterian - Saint Luke's Med Ctr, Chicago

77030

Baylor College of Medicine, Houston

77550

Univ TX Galveston Med Branch, Galveston

80204

Denver Public Health Dept / Disease Control Services, Denver

87131

Univ of New Mexico School of Medicine, Albuquerque

94103

ViRx Inc, San Francisco

94110

UCSF - San Francisco Gen Hosp, San Francisco

97210

Portland Veterans Adm Med Ctr / Rsch & Education Grp, Portland

98144

Univ of Washington / Pacific Med Ctr, Seattle

452670560

Univ of Cincinnati, Cincinnati

701122822

Louisiana State Univ Med School, New Orleans

06516

West Haven Veterans Administration Med Ctr, West Haven

02908

Roger Williams Med Ctr, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Glaxo Wellcome

INDUSTRY

NCT00002000 - A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients | Biotech Hunter | Biotech Hunter